Local funds launch Innovative Prostate Cancer Research

July 31, 2018

Local funds launch Innovative Prostate Cancer Research New prostate cancer research is underway at The Hormel Institute, thanks to grants funded by “Bowling for the Battle,” organized by the Tom Gillard family and Farmers Insurance. The two grants were established by the Institute and awarded internally to scientists with innovative ideas for advancing answers to Read more

Register for Ryan Gordon Memorial Golf Tournament

May 29, 2018

  Tournament raising funds for cancer research for 6th year  The Ryan Gordon Memorial Golf Tournament & Silent Auction is coming to Adams again this June. Started in 2013, the tournament has donated over $35,000 to The Hormel Institute to fund innovative cancer research. This year’s tournament and silent auction will take place on Saturday, Read more

PTTP Concert Tickets at More Locations

May 22, 2018

Tickets for the Paint the Town Pink concert on July 10 featuring Hotel California “A Salute to the Eagles” are now on sale at locations around Austin. Visit Austin Hy-Vee, Austin Area Chamber of Commerce, Austin ArtWorks Center, Coffee House on Main, or The Hormel Institute to purchase tickets. Tickets are $100 each and are Read more

Tagged , , , |

Another Institute Breakthrough – Lung Cancer Target Identified

May 11, 2018

Dr. Luke Hoeppner lab pinpoints protein involved in cancer growth A new target leading to a potential novel therapy for lung cancer was discovered through research led by Dr. Luke Hoeppner, head of the Molecular Biology and Translational Cancer lab of The Hormel Institute, University of Minnesota. The research, published in Communications Biology, is a Read more

Colon Cancer Metastasis Breakthrough Discovered at The Hormel Institute

May 1, 2018

Published discovery may lead to new therapy for deadly cancer  Dr. Tatyana Zykova, along with other scientists in the Cellular & Molecular Biology lab of The Hormel Institute, University of Minnesota, led by Dr. Zigang Dong, published breakthrough colon cancer research in the journal Molecular Cancer Therapeutics. Dr. Zykova and team discovered how a specific Read more

University of Minnesota and partners launch statewide cancer clinical trials network

April 11, 2018

New clinical trials network is funded in partnership with the State of Minnesota Minnesotans living in rural areas throughout greater Minnesota will soon have better access to new cancer treatments and enhanced care delivery, thanks to a new state-funded partnership between University of Minnesota and the state’s major health and research systems. As part of Read more

Ilana Chefetz Confronts Ovarian Cancer

April 2, 2018

The University of Minnesota researcher is on the front lines in the fight against the disease. Ilana Chefetz isn’t someone who backs down from a challenge. During her mandatory service in the Israeli military police back in 1997, a male colleague working with her to investigate a motorbike theft opined that young women were not cut Read more

Inflammation’s impact on cancer is a breakthrough

March 10, 2018

The Hormel Institute finds link in colon cancer prevention   Colon cancer could be better treated — or even prevented — thanks to continuing discoveries between inflammation and a common cellular process, established in new research by The Hormel Institute, University of Minnesota.  Dr. Ke Yao of Dr. Zigang Dong’s Cellular and Molecular Biology lab  published Read more

Institute scientist makes liver cancer breakthrough

February 16, 2018

Discovery suppresses liver tumor growth Dr. Ningling Kang and team from The Hormel Institute, University of Minnesota published exciting new research in the high impact journal Gastroenterology impacting liver cancer development. The research focuses on the role that specialized cells and enzymes play in tumor growth in the liver. The article, “P300 acetyltransferase mediates stiffness-induced Read more

Scientists identify new targets to restore damage caused by cancer development

February 7, 2018

Important discovery has potential for new cancer therapy The Hormel Institute’s Drs. Adrian Mansini, Estanislao Peixoto, Suji Jin, Kristen Thelen, and SURE intern researcher Maetzin Cruz-Reyes, along with lab section leader and professor Dr. Sergio Gradilone, published groundbreaking research in the high impact journal Hepatology. The article, “MiR-433 and miR-22 dysregulations induce HDAC6 overexpression and Read more